STERIS plc reports results for the quarter ended September 30 - Earnings Summary

What happened

STERIS reported adjusted earnings of $2.94 per share for the quarter ended September 30, up from $2.47 a year earlier and above analysts’ $2.68 average estimate. Revenue rose 8.8% to $1.59 billion, exceeding the $1.56 billion forecast; reported earnings per share were $2.19, and net income was $213.7 million.

Confirmed

Global impact / market context

Higher revenue and adjusted earnings indicate stronger quarterly business performance than analysts expected, which may support investor views of STERIS’s ability to generate sales and profit. However, reported earnings per share were lower than adjusted earnings, so investors may distinguish between the company’s headline adjusted result and its reported profit.

Analyst inference

Analysts’ average earnings estimate had declined about 0.8% over three months, with no revisions in the latest 30 days. The average rating remained “buy,” while shares were up 10.2% this quarter but down 8.7% year to date, suggesting mixed recent performance.

Confirmed

What to watch

1. Compare future reported earnings per share with adjusted earnings to see whether the gap narrows or persists, since the two measures show different views of quarterly profit. Analyst inference
2. Watch subsequent revenue and earnings against analyst forecasts; continued outperformance could reinforce expectations for sales growth, while weaker results could challenge those expectations. Analyst inference
3. Track whether analysts revise their earnings estimates after this report, as the average estimate had fallen about 0.8% over three months but was unchanged in the latest 30 days. Analyst inference

Evidence

• Original source link unavailable